Phreesia, Inc. (NYSE:PHR) Given Consensus Rating of “Moderate Buy” by Analysts

Shares of Phreesia, Inc. (NYSE:PHR) have been assigned a consensus rating of “Moderate Buy” from the twelve ratings firms that are presently covering the stock, MarketBeat reports. One research analyst has rated the stock with a hold rating and eleven have given a buy rating to the company. The average twelve-month price objective among brokerages that have issued a report on the stock in the last year is $29.42.

Several analysts have recently commented on PHR shares. JMP Securities reaffirmed a “market outperform” rating and set a $30.00 price objective on shares of Phreesia in a research report on Thursday, September 5th. Truist Financial lifted their price target on shares of Phreesia from $29.00 to $31.00 and gave the company a “buy” rating in a research note on Friday, September 6th. Robert W. Baird raised their price objective on Phreesia from $31.00 to $34.00 and gave the company an “outperform” rating in a research note on Friday, September 6th. Needham & Company LLC reissued a “buy” rating and issued a $29.00 price target on shares of Phreesia in a research report on Thursday, September 5th. Finally, DA Davidson reiterated a “buy” rating and set a $32.00 price target on shares of Phreesia in a research note on Thursday, September 5th.

Insider Activity

In other Phreesia news, insider Yvonne Hui sold 2,791 shares of Phreesia stock in a transaction that occurred on Tuesday, October 15th. The shares were sold at an average price of $20.92, for a total transaction of $58,387.72. Following the transaction, the insider now owns 27,228 shares of the company’s stock, valued at $569,609.76. The trade was a 9.30 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, COO Evan Roberts sold 1,843 shares of the stock in a transaction on Tuesday, October 15th. The stock was sold at an average price of $21.03, for a total transaction of $38,758.29. Following the completion of the sale, the chief operating officer now directly owns 753,876 shares of the company’s stock, valued at approximately $15,854,012.28. This trade represents a 0.24 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 29,997 shares of company stock worth $667,943 over the last 90 days. 5.80% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Phreesia

A number of hedge funds have recently made changes to their positions in the company. International Assets Investment Management LLC grew its holdings in Phreesia by 2,179.7% during the 3rd quarter. International Assets Investment Management LLC now owns 1,459 shares of the company’s stock valued at $33,000 after buying an additional 1,395 shares in the last quarter. nVerses Capital LLC grew its holdings in shares of Phreesia by 76.5% in the second quarter. nVerses Capital LLC now owns 3,000 shares of the company’s stock valued at $64,000 after purchasing an additional 1,300 shares in the last quarter. Lombard Odier Asset Management USA Corp bought a new stake in Phreesia in the second quarter worth $202,000. Quadrature Capital Ltd purchased a new stake in Phreesia during the first quarter valued at $202,000. Finally, Point72 DIFC Ltd bought a new position in Phreesia during the second quarter valued at $209,000. 92.10% of the stock is currently owned by hedge funds and other institutional investors.

Phreesia Stock Performance

Shares of PHR opened at $20.33 on Wednesday. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.03. The firm’s fifty day simple moving average is $20.63 and its two-hundred day simple moving average is $21.89. Phreesia has a 12 month low of $14.55 and a 12 month high of $29.16. The stock has a market capitalization of $1.17 billion, a P/E ratio of -11.29 and a beta of 0.94.

Phreesia (NYSE:PHR) last announced its earnings results on Wednesday, September 4th. The company reported ($0.31) EPS for the quarter, beating the consensus estimate of ($0.37) by $0.06. The company had revenue of $102.12 million for the quarter, compared to analyst estimates of $101.76 million. Phreesia had a negative return on equity of 39.34% and a negative net margin of 25.73%. As a group, analysts predict that Phreesia will post -1.23 EPS for the current year.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.